Evidence map›Paper›PMID 33419179›Full record

ArticleMolecules (Basel, Switzerland)2021

Gallato Zirconium (IV) Phtalocyanine Complex Conjugated with SiO2 Nanocarrier as a Photoactive Drug for Photodynamic Therapy of Atheromatic Plaque.

Yuriy Gerasymchuk, Wojciech Kałas, Jacek Arkowski, Łukasz Marciniak, Dariusz Hreniak, Edyta Wysokińska, Leon Strządała, Marta Obremska, Larysa Tomachynski, Viktor Chernii and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Application of Photodynamic Therapy in Cardiology.International journal of molecular sciences · 2024
    Review
  3. Novel CaO-SiONanomaterials (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yuriy GerasymchukInstitute of Low Temperature and Structure Research, Polish Academy of Sciences, ul. Okólna 2, 50-422 Wrocław, Poland.ORCID 0000-0002-2148-672X
Wojciech KałasLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wroclaw, Poland.
Jacek ArkowskiDepartment of Preclinical Studies, Wrocław Medical University, ul. K. Bartla 5, 51-618 Wrocław, Poland.
Łukasz MarciniakInstitute of Low Temperature and Structure Research, Polish Academy of Sciences, ul. Okólna 2, 50-422 Wrocław, Poland.ORCID 0000-0001-5181-5865
Dariusz HreniakInstitute of Low Temperature and Structure Research, Polish Academy of Sciences, ul. Okólna 2, 50-422 Wrocław, Poland.ORCID 0000-0003-1384-2314
Edyta WysokińskaLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wroclaw, Poland.ORCID 0000-0003-1003-2463
Leon StrządałaLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wroclaw, Poland.
Marta ObremskaDepartment of Preclinical Studies, Wrocław Medical University, ul. K. Bartla 5, 51-618 Wrocław, Poland.
Larysa TomachynskiV.I. Vernadskii Institute of General and Inorganic Chemistry, 32/34 Palladin Ave., 03-142 Kyiv, Ukraine.
Viktor CherniiV.I. Vernadskii Institute of General and Inorganic Chemistry, 32/34 Palladin Ave., 03-142 Kyiv, Ukraine.ORCID 0000-0003-2057-1639
Wiesław StrękInstitute of Low Temperature and Structure Research, Polish Academy of Sciences, ul. Okólna 2, 50-422 Wrocław, Poland.
Polish Academy of Sciences · PLLudwik Hirszfeld Institute of Immunology and Experimental Therapy · PLWroclaw Medical University · PL

Funding

Narodowe Centrum Nauki 2016/22/E/ST5/00530Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu Wroclaw Medical University Foundation support
6 · The paper itself

Abstract

A new conjugate of gallato zirconium (IV) phthalocyanine complexes (PcZrGallate) has been obtained from alkilamino-modified SiO

Indexed as

Coordination ComplexesDrug CarriersIndolesPhotochemotherapyPhotosensitizing AgentsPlaque, AtheroscleroticSilicon DioxideZirconiumAnimalsIsoindolesMiceRAW 264.7 CellsCoordination ComplexesDrug CarriersIndolesIsoindolesPhotosensitizing AgentsphthalocyanineSilicon DioxideZirconiumatherosclerosisaxially substitutedcell culturesmacrophagesphotodynamic therapyphotosensitizersROS generationSiO2 nanocarrierswater solublezirconium phthalocyanines

Identifiers

PMID33419179
PMCPMC7825541
OpenAlexW3119383240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.